Before approving a research protocol, an IRB/IEC must determine compliance with which of the following requirements?

According to U.S. federal regulations and international ethical guidelines, a primary responsibility of an Institutional Review Board (IRB) or Independent Ethics Committee (IEC) is to ensure the protection of human research subjects. A core criterion for approving research is upholding the ethical principle of Justice, which is operationalized by requiring that the selection of subjects is equitable. This means the IRB/IEC must determine that the burdens and potential benefits of the research are distributed fairly and that vulnerable populations are not targeted for risky research or unfairly excluded from potentially beneficial research. This is a mandatory determination for protocol approval.

A. A plan for the publication of study results is in place: While ethically encouraged for transparency, a formal publication plan is not a regulatory requirement for IRB/IEC approval of a research protocol.

C. The investigator has adequate access to patients eligible for the trial: This pertains to study feasibility, which is primarily the concern of the sponsor and institution, not a required ethical determination for the IRB/IEC.

D. The sponsor is qualified to provide oversight of the trial: Assessing the sponsor's qualifications is the responsibility of regulatory authorities (e.g., FDA), not the local IRB/IEC, whose focus is on the investigator and the protocol.

1. U.S. Department of Health & Human Services (HHS). Code of Federal Regulations, Title 45, Part 46.111(a)(3). "Criteria for IRB approval of research." This regulation explicitly states: "Selection of subjects is equitable. In making this assessment the IRB should take into account the purposes of the research and the setting in which the research will be conducted..."

2. U.S. Food and Drug Administration (FDA). Code of Federal Regulations, Title 21, Part 56.111(a)(3). "Criteria for IRB approval of research." This regulation mirrors the HHS requirement, stating that to approve research, the IRB must determine that: "Selection of subjects is equitable."

3. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979). The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Part C: Applications, Section 3 (Justice). The report states, "the principle of justice gives rise to moral requirements that there be fair procedures and outcomes in the selection of research subjects."

4. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). (2016). Guideline for Good Clinical Practice E6(R2). Section 3.1.2. This guideline requires the IRB/IEC to review "subject recruitment procedures" to ensure they are ethically sound, which inherently includes the principle of equitable selection.